TSBX
Price:
$0.3499
Market Cap:
$8.10M
Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, and uveal melanoma, as well as an investigator sponsored trial to treat cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. The company was founded in 2014 and is based in LA Jolla, California.
Industry
Biotechnology
IPO Date
2023-07-21
Stock Exchange
NASDAQ
Ticker
TSBX
According to Turnstone Biologics Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -0.11. This represents a change of -66.87% compared to the average of -0.33 of the last 4 quarters.
The mean historical PE Ratio of Turnstone Biologics Corp. over the last ten years is -0.32. The current -0.11 PE Ratio has changed 3.35% with respect to the historical average. Over the past ten years (40 quarters), TSBX's PE Ratio was at its highest in in the March 2023 quarter at 897.34. The PE Ratio was at its lowest in in the March 2022 quarter at -4.84.
Average
-0.32
Median
-0.35
Minimum
-7.92
Maximum
7.34
Discovering the peaks and valleys of Turnstone Biologics Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 7.34
Minimum Annual Increase = -207.90%
Minimum Annual PE Ratio = -7.92
Year | PE Ratio | Change |
---|---|---|
2024 | -0.16 | -69.69% |
2023 | -0.53 | -93.27% |
2022 | -7.92 | -207.90% |
The current PE Ratio of Turnstone Biologics Corp. (TSBX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.87
5-year avg
-0.32
10-year avg
-0.32
Turnstone Biologics Corp.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Turnstone Biologics Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Turnstone Biologics Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Turnstone Biologics Corp.'s PE Ratio?
How is the PE Ratio calculated for Turnstone Biologics Corp. (TSBX)?
What is the highest PE Ratio for Turnstone Biologics Corp. (TSBX)?
What is the 3-year average PE Ratio for Turnstone Biologics Corp. (TSBX)?
What is the 5-year average PE Ratio for Turnstone Biologics Corp. (TSBX)?
How does the current PE Ratio for Turnstone Biologics Corp. (TSBX) compare to its historical average?